There is a dearth of cannabis-related clinical studies, and Khiron Life Sciences (KHRN.V) is putting in the work to change that. Today, the company has begun its pre-clinical medical cannabis studies…
Reyes
The first time I watched The Big Short, I came away knowing less about finance than I did walking in. That’s not exactly true, but I became all too aware…
GW Pharmaceuticals (GWPH.Q) has received a recommendation from the European Medicines Agency (EMA) for the authorization of the company’s Epidyolex cannabis oral solution for use in the treatment of…
Namaste Technologies (N.V), cannabis’ favourite red-headed stepchild, hasn’t been having the best run lately, and being ordered to pay nearly USD$5M in cross-border settlements is just the chef’s kiss….
Beyond Meat (BYND.Q), the vegan burger maker we all know and love, has partnered with Dunkin’ Brands’ Group (DNKN.Q) to add its plant-based sausages to Dunkin’ Donuts menus in Manhattan, but…
On July 22, 2019, the U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Holdings (CURA.C) via overnight delivery. The message was plain: Four of the company’s CBD-infused…
The investigation via special committee of CannTrust Holdings’ (TRST.C) non-compliance with Health Canada mandated regulations is ongoing, with further information regarding the committee’s membership now available. On July 11,…
Aurora Cannabis (ACB.T) has been named as the sole winner in the Italian medical cannabis tender process, an announcement tempered by worries over the company’s mounting debt and disappointing revenue….
Supreme (FIRE.T) is an office darling for a few reasons, but none more so than the fact it’s a company you can be proud recommending to friends and family. I…
Supreme Cannabis (FIRE.T) subsidiary, Blissco, was a nice little craft grower when it hit the public markets last year, but what Supreme saw in them was more than a…